Table of Contents [1–25 of 143 articles]

• Table of Contents for Year 2016
• EVASEP: A Noninterventional Study Describing the Perception of Neurologists, Patients, and Caregivers on Caregivers’ Role in the Support of Patients Suffering from Multiple Sclerosis Treated with Subcutaneous Interferon Beta 1a, Cécile Donzé, Bruno Lenne, Anne-Sophie Jean Deleglise, Christian Kempf, Yasmine Bellili, and Patrick Hautecoeur
  Volume 2016 (2016), Article ID 4986073, 10 pages
• Retracted: Consensus Guidelines for CSF and Blood Biobanking for CNS Biomarker Studies, Multiple Sclerosis International
  Volume 2016 (2016), Article ID 8304273, 1 page
• Healthy Aging from the Perspectives of 683 Older People with Multiple Sclerosis, Elizabeth M. Wallack, Hailey D. Wiseman, and Michelle Ploughman
  Volume 2016 (2016), Article ID 1845720, 10 pages
• The Incidence of Euphoria in Multiple Sclerosis: Artefact of Measure, Amy Duncan, Susan Malcolm-Smith, Ozayr Ameen, and Mark Solms
  Volume 2016 (2016), Article ID 5738425, 8 pages
• The Efficacy of Functional Electrical Stimulation of the Abdominal Muscles in the Treatment of Chronic Constipation in Patients with Multiple Sclerosis: A Pilot Study, Christine Singleton, Abdel Magid Bakheit, and Carla Peace
  Volume 2016 (2016), Article ID 4860315, 4 pages
• Management of Multiple Sclerosis in the Breastfeeding Mother, Saneea Almas, Jesse Vance, Teresa Baker, and Thomas Hale
  Volume 2016 (2016), Article ID 6527458, 10 pages
• Lack of Association between Pulse Steroid Therapy and Bone Mineral Density in Patients with Multiple Sclerosis, Serap Zengin Karahan, Cavit Boz, Sevgi Kilic, Nuray Can Usta, Mehmet Ozmenoglu, Vildan Altunayoglu Cakmak, and Sibel Gazioglu
  Volume 2016 (2016), Article ID 5794910, 7 pages
• Table of Contents for Year 2015
• Stride-Time Variability and Fall Risk in Persons with Multiple Sclerosis, Yaejin Moon, Douglas A. Wajda, Robert W. Motl, and Jacob J. Sosnoff
  Volume 2015 (2015), Article ID 964790, 7 pages
• The Therapeutic Potential of the Ketogenic Diet in Treating Progressive Multiple Sclerosis, Mithu Storoni and Gordon T. Plant
  Volume 2015 (2015), Article ID 681289, 9 pages
• The Communication of Multiple Sclerosis Diagnosis: The Patients’ Perspective, Maria Josè Messina, Gloria Dalla Costa, Mariaemma Rodegher, Lucia Moiola, Bruno Colombo, Giancarlo Comi, and Vittorio Martinelli
  Volume 2015 (2015), Article ID 353828, 7 pages
• Comparing Three Dual-Task Methods and the Relationship to Physical and Cognitive Impairment in People with Multiple Sclerosis and Controls, Megan C. Kirkland, Elizabeth M. Wallack, Samantha N. Rancourt, and Michelle Ploughman
  Volume 2015 (2015), Article ID 650645, 7 pages
• Adipsin Is Associated with Multiple Sclerosis: A Follow-Up Study of Adipokines, Renuka Natarajan, Sanna Hagman, Mari Hämälainen, Tiina Leppänen, Prasun Dastidar, Eeva Moilanen, and Irina Elovaara
  Volume 2015 (2015), Article ID 371734, 9 pages
• Neuroimaging of Natalizumab Complications in Multiple Sclerosis: PML and Other Associated Entities, Justin M. Honce, Lidia Nagae, and Eric Nyberg
  Volume 2015 (2015), Article ID 809252, 14 pages
• Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study, Rocco Totaro, Caterina Di Carmine, Gianfranco Costantino, Roberta Fantozzi, Paolo Bellantonio, Aurora Fuiani, Ciro Mundi, Stefano Ruggieri, Carmine Marini, and Antonio Carolei
  Volume 2015 (2015), Article ID 763418, 7 pages
• Prevalence of Depression and Anxiety among Patients with Multiple Sclerosis Attending the MS Clinic at Sheikh Khalifa Medical City, UAE: Cross-Sectional Study, Taoufik Alsaadi, Khadija El Hammasi, Tarek M. Shahrour, Mustafa Shakra, Lamya Turkawi, Abdulla Mudhafar, Lina Diab, and Mufeed Raoof
  Volume 2015 (2015), Article ID 487159, 5 pages
• EDSS Change Relates to Physical HRQoL While Relapse Occurrence Relates to Overall HRQoL in Patients with Multiple Sclerosis Receiving Subcutaneous Interferon β-1a, Barbara G. Vickrey, Liesly Lee, Fraser Moore, and Patrick Moriarty
  Volume 2015 (2015), Article ID 631989, 6 pages
• Antiepileptic and Antidepressive Polypharmacy in Patients with Multiple Sclerosis, Georg Anton Giæver Beiske, Trygve Holmøy, Antonie Giæver Beiske, Svein I. Johannessen, and Cecilie Johannessen Landmark
  Volume 2015 (2015), Article ID 317859, 7 pages
• Development of Activity-Related Muscle Fatigue during Robot-Mediated Upper Limb Rehabilitation Training in Persons with Multiple Sclerosis: A Pilot Trial, Johanna Renny Octavia, Peter Feys, and Karin Coninx
  Volume 2015 (2015), Article ID 650431, 11 pages
• Applying an Open-Source Segmentation Algorithm to Different OCT Devices in Multiple Sclerosis Patients and Healthy Controls: Implications for Clinical Trials, Pavan Bhargava, Andrew Lang, Omar Al-Louzi, Aaron Carass, Jerry Prince, Peter A. Calabresi, and Shiv Saidha
  Volume 2015 (2015), Article ID 136295, 10 pages
• The Lived Experience of Multiple Sclerosis Relapse: How Adults with Multiple Sclerosis Processed Their Relapse Experience and Evaluated Their Need for Postrelapse Care, Miho Asano, Karli Hawken, Merrill Turpin, Abby Eitzen, and Marcia Finlayson
  Volume 2015 (2015), Article ID 351416, 8 pages
• Does Self-Efficacy Affect Cognitive Performance in Persons with Clinically Isolated Syndrome and Early Relapsing Remitting Multiple Sclerosis?, Peter Joseph Jongen, Keith Wesnes, Björn van Geel, Paul Pop, Hans Schrijver, Leo H. Visser, H. Jacobus Gilhuis, Ludovicus G. Sinnige, and Augustina M. Brands
  Volume 2015 (2015), Article ID 960282, 8 pages
• Epidemiology of Neuromyelitis Optica in the World: A Systematic Review and Meta-Analysis, Masoud Etemadifar, Zahra Nasr, Behrang Khalili, Maryam Taherioun, and Reza Vosoughi
  Volume 2015 (2015), Article ID 174720, 8 pages
• Italian Validation of the 12-Item Multiple Sclerosis Walking Scale, C. Solaro, E. Trabucco, A. Signori, M. Cella, M. Messmer Uccelli, G. Brichetto, P. Cavalla, M. Gironi, F. Patti, and L. Prosperini
  Volume 2015 (2015), Article ID 540828, 6 pages
• Disease-Modifying Drugs Reduce Cortical Lesion Accumulation and Atrophy Progression in Relapsing-Remitting Multiple Sclerosis: Results from a 48-Month Extension Study, Francesca Rinaldi, Paola Perini, Matteo Atzori, Alice Favaretto, Dario Seppi, and Paolo Gallo
  Volume 2015 (2015), Article ID 369348, 5 pages
• Intrathecal IgG Synthesis: A Resistant and Valuable Target for Future Multiple Sclerosis Treatments, Mickael Bonnan
  Volume 2015 (2015), Article ID 296184, 15 pages